WIT Legal Releases 2nd Annual Report on Trends in Hatch-Waxman Litigation

The new report examines Abbreviated New Drug Application (ANDA) cases and the Orange Book-listed products at issue throughout 2024. NEW YORK, Feb. 3, 2025 /PRNewswire/ — WIT Legal (“WIT”), the leading agency representing testifying experts for high-stakes, complex legal matters, today…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.